account_id none on file
legal_name Chemomab Therapeutics Ltd.
ticker CMMB
cik 1534248
domain chemomab.com
linkedin_company_url https://www.linkedin.com/company/chemoab-ltd
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
hq Tel Aviv, Israel
sector index/company/sector/health-care/
calls 0 filings 7 executives 6 family 0
why_nownone on file
callsnone on file
filings
Adi Mor | 44 | Director, Chief Executive Officer and Chief Scientific Officer
filing / Mar 23, 2026 / receipt
Sigal Fattal | 55 | Chief Financial Officer
filing / Mar 23, 2026 / receipt
John Lawler | 59 | Chief Development Officer
filing / Mar 23, 2026 / receipt
Cypher's independent analysis powered by its rich AI precision medicine platform identified CCL24 inhibition as the top-ranked clinical stage therapeutic opportunity for RA, strongly validating the st
company_statement / Sep 10, 2026 / receipt
We believe this transaction provides Chemomab stockholders with meaningful ownership in a combined company that is well-funded to advance Nebocitag into a large indication with substantial unmet needs
company_statement / Sep 10, 2026 / receipt
We have an established care-water relationship within the rheumatology community, and we have an efficient commercial team that can be scaled rapidly. | Explicit statement of intent to scale the comme
ir_statement / Sep 10, 2026 / receipt
We spent years developing spectra, our AI network medicine platform, which integrates large-scale transatomic data and network biology to identify molecular treatment response signatures and support t
company_statement / Sep 10, 2026 / receipt
executives
| Adi Mor | Director, Chief Executive Officer and Chief Scientific Officer | - | receipt |
| Andrew Fine | Chief Financial Officer | - | receipt |
| Donald Marvin | Chief Financial Officer | - | receipt |
| John Lawler | Chief Development Officer | - | receipt |
| Neil Cohen | Chief Executive Officer | - | receipt |
| Sigal Fattal | Chief Financial Officer | receipt |
familynone on file
upcomingnone on file
changes
| 2023-06-16 | Chief Financial Officer, appointed | sec_8k |
| 2023-06-05 | Chief Executive Officer, appointed | sec_8k |
| 2023-06-05 | Chief Financial Officer, appointed | sec_8k |
| 2021-11-12 | Chief Financial Officer, appointed | sec_8k |
| 2021-11-08 | Chief Financial Officer, appointed | sec_8k |
| 2020-10-20 | Chief Executive Officer, appointed | sec_8k |
| 2020-10-20 | Chief Financial Officer, appointed | sec_8k |
mcp_package_hint
slug chemomab-therapeutics-ltd
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$